Section Arrow
Quote
CLGN.NASDAQ
- CollPlant Biotechnologies Ltd
(Financial Status)
Quotes are at least 15-min delayed:2026/04/16 06:58 EDT
Pre Market
Last
 0.3228
+0.003 (+0.94%)
Bid
0.327
Ask
0.365
High 0.365 
Low 0.32 
Volume 10.26K 
Regular Hours (Closed)
Last
 0.3198
+0.0265 (+9.04%)
Day High 
0.365 
Prev. Close
0.2933 
1-M High
0.85 
Volume 
368.86K 
Bid
0.327
Ask
0.365
Day Low
0.2711 
Open
0.29 
1-M Low
0.275 
Market Cap 
4.23M 
Currency 美元 
P/E -- 
%Yield 5.46 
10-SMA 0.41 
20-SMA 0.52 
50-SMA 0.65 
52-W High 4.98 
52-W Low 0.275 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.94/-0.56
Enterprise Value
6.26M
Balance Sheet
Book Value Per Share
0.42
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.37M
Operating Revenue Per Share
0.75
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IMMPImmutep Limited0.544+0.2292+72.81%-- 
Pre Market 0.5623 +0.0183 +3.36%
LIMNLiminatus Pharma Inc0.1856+0.0058+3.23%-- 
Pre Market 0.1856 0 0.00%
PPCBPropanc Biopharma Inc0.1106+0.0131+13.44%0PE
Pre Market 0.0956 -0.015 -13.56%
ALLOAllogene Therapeutics2.17-0.11-4.82%-- 
Pre Market 2.18 +0.01 +0.46%
CUECue Biopharma0.7243+0.2863+65.37%-- 
Pre Market 0.6367 -0.0876 -12.09%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.